Tuesday, May 21
|
||
Time | Session Title | Speakers |
8:55 – 9:00 AM | Introduction | Allison Schmitt, BCLT |
9:00 – 9:45 AM |
Impacts of AI’s Rapid Rise in the Life Sciences |
Michelle Chen, In Silico |
9:50 – 10:35 AM |
Licensing and Deals Update: Universities and Private Parties |
Ryan Daniel, Fresenius Kabi |
10:35 – 10:50 AM |
Break |
|
10:50 – 11:25 AM |
Life Sciences Funding Models and Mechanisms |
Paul Billings, Biological Dynamics |
11:30 – 12:00 PM |
Amgen One Year Out: What Have We Learned? |
Doug Behrens, Covington
|
12:00-12:30 |
Lunch Break |
|
12:30 – 1:10 PM |
Obviousness-Type Double Patenting post-Cellect: Strategies and Best Practices |
Gabrielle LaHatte, Latham
|
1:15 – 2:00 PM |
Anti-Counterfeiting & Patient Safety |
Lori Mayall, Gilead |
Wednesday, May 22
|
||
Time | Session Title | Speakers |
8:55 – 9:00 AM |
Introduction to Day 2 |
Allison Schmitt, Berkeley Center for Law & Technology |
9:00 – 9:50 AM |
Interplay of Patent and Regulatory Exclusivity – National and Global Considerations |
Kurt Karst, Hyman, Phelps & McNamara |
9:55 – 10:55 AM |
Future Pandemic Preparedness – Use of IP and Data |
Allison Schmitt, BCLT |
10:55 – 11:10 AM | Break | |
11:10 – 11:55 AM |
Trade Secrets v. Patents – Key Strategic Decisions |
Gargi Talukder, Orrick |